Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001560259-13-000002
Filing Date
2013-07-23
Accepted
2013-07-23 16:45:20
Documents
1

Document Format Files

Seq Description Document Type Size
1 NEUSTRADA CAPITAL LLC/GERRY CATENACCI 13D AMENDMENT neustrada13da.txt SC 13D/A 6287
  Complete submission text file 0001560259-13-000002.txt   8137
Mailing Address 25 HEALTH SCIENCES DRIVE SUITE 113 STONY BROOK NY 11790
Business Address 25 HEALTH SCIENCES DRIVE SUITE 113 STONY BROOK NY 11790 631 444 6861
APPLIED DNA SCIENCES INC (Subject) CIK: 0000744452 (see all company filings)

EIN.: 592262718 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SC 13D/A | Act: 34 | File No.: 005-78682 | Film No.: 13981761
SIC: 2860 Industrial Organic Chemicals

Mailing Address 126 EAST 56TH STREET 25TH FLOOR NEW YORK NY 10022
Business Address 126 EAST 56TH STREET 25TH FLOOR NEW YORK NY 10022 646-291-8822
NeuStrada Capital LLC (Filed by) CIK: 0001560259 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1212
Type: SC 13D/A